Priyanka Belawat

Dr. Priyanka Belawat is an experienced investment advisor and board member in the healthcare and biotechnology sectors. She currently serves as an Investment Advisor at HBM Partners, a position she has held for over thirteen years.35

Professional Experience

Dr. Belawat has extensive experience in venture and private equity investing in the healthcare space, spanning more than a decade.1 Her expertise includes:

• Venture and private equity investing
• Portfolio management
• Board representation for multiple biotech and pharmaceutical companies

Board Positions

Dr. Belawat holds several board positions in prominent biotech and pharmaceutical companies:

• Board member at Adrenomed AG, a German biopharmaceutical company focused on treating life-threatening conditions23
• Director at Neurelis Inc., a neuroscience-focused company in the USA13
• Board member at BioAtla, a US-based biotechnology company3
• Board member at iTeos Therapeutics SA4
• Board member at Mahzi Therapeutics, Inc.4

Educational Background

Dr. Belawat's academic credentials include:

• Doctorate in molecular biology and genetics from the University of Zurich
• Completed post-doctorate work at Hong Kong University of Science and Technology (HKUST)1

Areas of Expertise

Throughout her career, Dr. Belawat has demonstrated expertise in:

• Biotech and pharmaceutical investments
• Indian pharmaceutical sector
• Public equity, fund, and direct private investments
• Portfolio management in areas such as biotech, pharma diagnostics, and healthcare services1

Dr. Priyanka Belawat's LinkedIn username is priyankabelawat, as mentioned in the query.